- Case report
- Open Access
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
© The Author(s) 2019
- Received: 17 October 2018
- Accepted: 5 January 2019
- Published: 23 January 2019
To report the clinical course and the multimodal retinal imaging of a spontaneous retinal pigment epithelial (RPE) tear in a type 2 choroidal neovascularization (CNV) secondary to age-related macular degeneration treated with anti-vascular endothelial growth factor (VEGF) treatment.
A 74 year-old man presented with visual acuity deterioration in the right eye. Multimodal retinal imaging showed a predominantly classic (type 2) CNV complicated by a spontaneous RPE tear. The patient received six intravitreal injections of anti-VEGF which resulted in improvement of the vision and stabilization of the neovascular lesion on optical coherence tomography (OCT). Longitudinal changes of the RPE-photoreceptors interface, including RPE splitting, are reported on OCT.
RPE tears may spontaneously occur in type 2 CNV. Anti-VEGF treatment should be aimed at promoting RPE repair and limiting the extent of the scarring. The mechanisms of RPE repair during treatment may be documented with OCT.
- Age-related macular degeneration
- Anti-VEGF therapy
- Choroidal neovascularization
- Multimodal retinal imaging
- Repair mechanism
- Retinal pigment epithelial tear
Retinal pigment epithelial (RPE) tears are a well recognised complication of neovascular age-related macular degeneration (nAMD) ; they can occur spontaneously or follow treatment with either anti-vascular endothelial growth factor (VEGF) agents or laser treatment, such as photodynamic therapy .
RPE tears have been mainly associated with the presence of a pigment epithelial detachment (PED) in the setting of different neovascular subtypes of AMD .
To the best of our knowledge, RPE tears have not been reported to occur during the natural history of type 2 (predominantly classic) choroidal neovascularizations (CNVs) secondary to AMD.
We report the clinical course and the multimodal retinal imaging of a spontaneous RPE tear in a type 2 CNV which was subsequently treated with anti-VEGF treatment.
RPE tears have been reported as part of the natural history of nAMD [2, 3]. Nowadays RPE tears are more commonly encountered after anti-VEGF treatment, although their incidence is relatively rare [4, 5].
Pathogenesis and repair mechanisms of RPE tears have not been fully elucidated. Established risk factors for RPE tear development are presence of PED, height of the PED and contracting folds in the RPE contour . Anti-VEGF treatment seems to increase the risk of early tearing, possibly by shrinking the neovascular complex, thereby stretching the RPE to the breaking point .
Of note our patient presented with a type 2 (predominantly classic) CNV. RPE tears are extremely rare in type 2 CNVs and only two studies documented RPE tears occurring after anti-VEGF treatment in this subtype of CNV [7, 8]. However to the best of our knowledge RPE tears have not been documented during the natural history of type 2 CNVs secondary to AMD. Thus we report for the first time the multimodal retinal imaging of a spontaneous RPE tear in a type 2 CNV and we report repair mechanisms following anti-VEGF treatment.
In 1984 Gass  used fundus examinations and fluorescein angiography to describe the natural history and the tissue remodelling occurring in RPE tears secondary to nAMD. He hypothesized regrowth of hypopigmented pigment epithelium in the area where RPE was absent. 2 years later Chuang and Bird  supported Gass observations by reporting that in most cases the RPE defect was replaced by a plaque of fibrous tissue; in a few lesions the inner surface of Bruch’s membrane was observed to become covered by tissue with morphological features similar to the normal RPE .
The advent of high resolution OCT has made it possible to study the RPE-photoreceptors interface in more details. Recently Mukai et al. . reported the longitudinal changes of the RPE tears on high resolution OCT and their findings supported the previously observed RPE remodelling [9, 10]. They observed that persistent subretinal fluid was associated with the repair process leading to fibrous tissue, while early subretinal fluid resolution was associated with the repair process leading to proliferative tissue ingrowth along Bruch’s membrane .
These observations have therapeutical implications and outline that when a RPE tear occur, regular treatment may stop the CNV from leaking and limit the retinal scarring . Of note, in a recent study  it has been shown that the long-term visual outcome in eyes affected by RPE tears seems to be related more to the patient’s response to therapy than to the tear itself.
Recent multimodal retinal imaging studies showed ‘in vivo’ longitudinal plasticity of the RPE during anti-VEGF treatment of different subtypes of nAMD [13, 14]. An interesting reported finding is the splitting of the RPE into two distinct hyperreflective bands followed by the envelopment of the hyperreflective neovascular lesion on the OCT scan . This latter finding is most commonly observed in type 2 CNV [14, 15] and indicates dynamic repair mechanisms of the RPE in the context of the subretinal neovascular lesion. Indeed it is known that in response to various stimuli, RPE cells are capable of hypertrophy, proliferation, and intraretinal migration. Such changes are commonly seen in AMD and have been reported on both high-resolution OCT and histologic sections [16, 17].
In line with the previous studies [13–15], our patient’s OCT scan showed prompt splitting of the hyperreflective line attributable to the RPE and envelopment of the hyperreflective neovascular lesion after anti-VEGF treatment.
In summary, RPE tears may spontaneously occur in type 2 CNV secondary to AMD. In such scenario, our case indicates that anti-VEGF treatment should be aimed at promoting RPE repair mechanisms and limiting the extent of the scarring. The mechanisms of RPE repair during treatment may be documented with OCT.
Contributions of authors in each of these areas: Conception and design (GC). Analysis and interpretation (GC, VS, PAK, UC). Writing the article (GC, VS, UC). Critical revision of the article (GC, PAK, UC). Data collection (GC, SD). Literature search (GC, SD). All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Availability of data and materials
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Ethics approval and consent to participate
Informed consent for publication of clinical details and/or clinical images was obtained from the patient.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Ersoz MG, Karacorlu M, Arf S, Sayman Muslubas I, Hocaoglu M. Retinal pigment epithelium tears: classification, pathogenesis, predictors, and management. Surv Ophthalmol. 2017;62:493–505.View ArticleGoogle Scholar
- Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol. 1981;65:417–22.View ArticleGoogle Scholar
- Pauleikhoff D, Löffert D, Spital G, et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol. 2002;240:533–8.View ArticleGoogle Scholar
- Cunningham ET Jr, Feiner L, Chung C, et al. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration. Ophthalmology. 2011;118:2447–52.View ArticleGoogle Scholar
- Vazquez-Alfageme C, Nicholson L, Hamilton RD, Patel PJ. Incidence and long-term visual acuity of retinal pigment epithelium tears after intravitreal anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration. Retina. 2018. https://doi.org/10.1097/IAE.0000000000002029.View ArticlePubMedGoogle Scholar
- Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Am J Ophthalmol. 2013;156(981–988):e2.Google Scholar
- Arias L, Caminal JM, Rubio M, Pujol O, Arruga J. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization. Eur J Ophthalmol. 2007;17:992–5.View ArticleGoogle Scholar
- Konstantinidis L, Ambresin A, Zografos L, Mantel I. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration. Acta Ophthalmol. 2010;88:736–41.View ArticleGoogle Scholar
- Gass JD. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol. 1984;68:513–9.View ArticleGoogle Scholar
- Chuang EL, Bird AC. Repair after tears of the retinal pigment epithelium. Eye (Lond). 1988;2(Pt 1):106–13.View ArticleGoogle Scholar
- Mukai R, Sato T, Kishi S. Repair mechanism of retinal pigment epithelial tears in age-related macular degeneration. Retina. 2015;35:473–80.View ArticleGoogle Scholar
- Invernizzi A, Nguyen V, Arnold J, Young S, Barthelmes D, Gillies MC. Early and late retinal pigment epithelium tears after anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Ophthalmology. 2018;125:237–44.View ArticleGoogle Scholar
- Casalino G, Bandello F, Chakravarthy U. Changes in neovascular lesion hyperreflectivity after anti-VEGF treatment in age-related macular degeneration: an integrated multimodal imaging analysis. Invest Ophthalmol Vis Sci. 2016;57:OCT288–98.View ArticleGoogle Scholar
- Casalino G, Stevenson MR, Bandello F, Chakravarthy U. Tomographic biomarkers predicting progression to fibrosis in treated neovascular age-related macular degeneration: a multimodal imaging study. Ophthalmol Retina. 2018;2:451–61.View ArticleGoogle Scholar
- Dolz-Marco R, Phasukkijwatana N, Sarraf D, Freund KB. Regression of type 2 neovascularization into a type 1 pattern after intravitreal anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Retina. 2017;37:222–33.View ArticleGoogle Scholar
- Ho J, Witkin AJ, Liu J, Chen Y, Fujimoto JG, Schuman JS, Duker JS. Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2011;118:687–93.View ArticleGoogle Scholar
- Zanzottera EC, Ach T, Huisingh C, Messinger JD, Freund KB, Curcio CA. Visualizing retinal pigment epithelium phenotypes in the transition to atrophy in neovascular age-related macular degeneration. Retina. 2016;36(Suppl 1):S26–39.View ArticleGoogle Scholar